Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)
View ORCID ProfilePhilip M Bath, Jonathan Ball, Matthew Boyd, Heather Gage, Matthew Glover, Maureen Godfrey, Bruce Guthrie, Jonathan Hewitt, Robert Howard, Thomas Jaki, Edmund Juszczak, Daniel Lasserson, Paul Leighton, Val Leyland, Wei Shen Lim, Pip Logan, Garry Meakin, Alan Montgomery, Reuben Ogollah, Peter Passmore, Philip Quinlan, Caroline Rick, Simon Royal, Susan D Shenkin, Clare Upton, Adam L Gordon the PROTECT-CH Trialists
doi: https://doi.org/10.1101/2022.08.29.22279359
Philip M Bath
1Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, NG7 2UH, UK
2Stroke, Nottingham University Hospitals NHS Trust, Queen’s Medical Centre, Derby Road, Nottingham NG7 2UH, UK
Jonathan Ball
3Infections, Immunity and Microbes, School of Life Sciences, University of Nottingham, Nottingham, NG7 2UH, UK
Matthew Boyd
4Division of Pharmacy Practice and Policy, School of Pharmacy, University of Nottingham, NG7 2RD, UK
Heather Gage
5Surrey Health Economics Centre, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, GU2 7YW, UK
Matthew Glover
5Surrey Health Economics Centre, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, GU2 7YW, UK
Maureen Godfrey
6c/o Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Bruce Guthrie
7Advanced Care Research Centre, Usher Institute, University of Edinburgh, Edinburgh, EH8 9AG, UK
Jonathan Hewitt
8Department of Geriatric Medicine, Llandough Hospital, Penarth, CF64 2XX, UK
Robert Howard
9Division of Psychiatry, University College London, London W1T 7NF UK
Thomas Jaki
10MRC Biostatistics Unit, University of Cambridge, Cambridge, CB2 0SR UK
Edmund Juszczak
11Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Daniel Lasserson
12Acute Ambulatory Care, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK
13Ambulatory Assessment Unit, Department of Geratology, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 9DU, UK
Paul Leighton
14Lifespan and Population Sciences, School of Medicine, University of Nottingham, Nottingham, NG7 2UH, UK
Val Leyland
15Bramcote, Nottingham NG9 UK
Wei Shen Lim
16Respiratory Medicine, Nottingham University Hospitals NHS Trust, Nottingham, NG5 1PB
Pip Logan
17Unit of Injury, Inflammation and Recovery, School of Medicine, University of Nottingham, NG7 2UH, UK
18Nottingham City Care Partnership, Nottingham, NG6 8WR, UK
Garry Meakin
11Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Alan Montgomery
11Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Reuben Ogollah
11Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Peter Passmore
19Centre for Public Health, Institute for Clinical sciences, Queen’s University Belfast, Grosvenor Road, Belfast BT12 6BJ
Philip Quinlan
20Digital Health & Digital Research Service, University of Nottingham, Nottingham, NG7 2UH, UK
Caroline Rick
11Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Simon Royal
21University of Nottingham Health Service, Cripps Health Centre, University Park, Nottingham NG7 2QW UK
Susan D Shenkin
22Ageing and Health, Usher Institute and Advanced Care Research Centre, University of Edinburgh, Edinburgh, EH16 4SB, UK
Clare Upton
11Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, NG7 2UH, UK
Adam L Gordon
23NIHR Applied Research Collaboration-East Midlands (ARC-EM), Institute of Mental Health, Triumph Road, Nottingham. NG7 2TU.
24Division of Medical Sciences and Graduate Entry Medicine, University of Nottingham, Derby Medical School, Royal Derby Hospital, Derby, DE22 3NE, UK
Data Availability
The trial never recruited patients so no data are available.
Posted August 31, 2022.
Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)
Philip M Bath, Jonathan Ball, Matthew Boyd, Heather Gage, Matthew Glover, Maureen Godfrey, Bruce Guthrie, Jonathan Hewitt, Robert Howard, Thomas Jaki, Edmund Juszczak, Daniel Lasserson, Paul Leighton, Val Leyland, Wei Shen Lim, Pip Logan, Garry Meakin, Alan Montgomery, Reuben Ogollah, Peter Passmore, Philip Quinlan, Caroline Rick, Simon Royal, Susan D Shenkin, Clare Upton, Adam L Gordon
medRxiv 2022.08.29.22279359; doi: https://doi.org/10.1101/2022.08.29.22279359
Prophylactic Treatment of COVID-19 in Care Homes Trial (PROTECT-CH)
Philip M Bath, Jonathan Ball, Matthew Boyd, Heather Gage, Matthew Glover, Maureen Godfrey, Bruce Guthrie, Jonathan Hewitt, Robert Howard, Thomas Jaki, Edmund Juszczak, Daniel Lasserson, Paul Leighton, Val Leyland, Wei Shen Lim, Pip Logan, Garry Meakin, Alan Montgomery, Reuben Ogollah, Peter Passmore, Philip Quinlan, Caroline Rick, Simon Royal, Susan D Shenkin, Clare Upton, Adam L Gordon
medRxiv 2022.08.29.22279359; doi: https://doi.org/10.1101/2022.08.29.22279359
Subject Area
Subject Areas
- Addiction Medicine (329)
- Allergy and Immunology (648)
- Anesthesia (173)
- Cardiovascular Medicine (2484)
- Dermatology (209)
- Emergency Medicine (384)
- Epidemiology (11947)
- Forensic Medicine (10)
- Gastroenterology (714)
- Genetic and Genomic Medicine (3874)
- Geriatric Medicine (358)
- Health Economics (648)
- Health Informatics (2503)
- Health Policy (963)
- Hematology (350)
- HIV/AIDS (812)
- Medical Education (384)
- Medical Ethics (106)
- Nephrology (411)
- Neurology (3638)
- Nursing (204)
- Nutrition (542)
- Oncology (1887)
- Ophthalmology (549)
- Orthopedics (229)
- Otolaryngology (298)
- Pain Medicine (240)
- Palliative Medicine (71)
- Pathology (459)
- Pediatrics (1066)
- Primary Care Research (434)
- Public and Global Health (6305)
- Radiology and Imaging (1335)
- Respiratory Medicine (845)
- Rheumatology (388)
- Sports Medicine (333)
- Surgery (424)
- Toxicology (51)
- Transplantation (179)
- Urology (152)